# Cohance Lifesciences Limited – FDA Inspection, Mar 1, 2019

Source: https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/d292ee89-2212-427b-8fc0-c520be0929d7
Source feed: FDA_Inspections

> FDA inspection 1087850 of Cohance Lifesciences Limited, March 01, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087850
- Company Name: Cohance Lifesciences Limited
- Inspection Date: 2019-03-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1289854 - 2025-09-11
- FDA Inspection 978256 - 2016-04-01
- FDA Inspection 794863 - 2012-08-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/latorie-s-jones/086d0897-7d63-4fa8-bdce-f1d17885abd7)

Company: https://www.keypedia.com/companies/cohance-lifesciences-limited/e712f9d0-36ff-477a-8b91-bf3c314e7b2e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c